39.96
Vera Therapeutics Inc Azioni (VERA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
|
|
12.24%
94.21
|
83.93 | 80.14 | 57.19 | 48.91 |
| Operating Income/Loss |
12.24%
-94.21
|
-83.93 | -80.14 | -57.19 | -48.91 |
| Nonoperating Income/Loss |
14.54%
3.11
|
3.639 | 3.61 | 5.50 | 5.49 |
| Income/Loss From Continuing Operations Before Tax |
13.45%
-91.10
|
-80.29 | -76.53 | -51.69 | -43.42 |
| Income/Loss From Continuing Operations After Tax |
13.46%
-91.10
|
-80.29 | -76.53 | -51.69 | -43.42 |
|
|
13.46%
-91.10
|
-80.29 | -76.53 | -51.69 | -43.42 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.27%
0.4639
|
63.85 | 63.79 | 63.67 | 1.7888 |
| Diluted Average Shares |
99.27%
0.4639
|
63.85 | 63.79 | 63.67 | 1.7888 |
| Basic Earnings Per Share |
10.32%
-1.39
|
-1.26 | -1.20 | -0.81 | -0.72 |
| Diluted Earnings Per Share |
10.32%
-1.39
|
-1.26 | -1.20 | -0.81 | -0.72 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):